Tecentriq.com
| Top centri sites |
- Title
- Treatment for mUC & NSCLC |TECENTRIQ® (atezolizumab)
- Meta Description
- Find information about TECENTRIQ® (atezolizumab) Advanced Urothelial Carcinoma (mUC) or metastatic non-small cell lung cancer (NSCLC) treatment. INDICATION: TECENTRIQ is a prescription medicine used to treat a type of bladder and urinary tract cancer called urothelial carcinoma. TECENTRIQ may be used when your bladder cancer: has spread or cannot be removed by surgery (advanced urothelial carcinoma), and you are not able to take chemotherapy that contains a medicine called cisplatin, or you have tried chemotherapy that contains platinum, and it did not work or is no longer working. The approval of TECENTRIQ in these patients is based on a study that measured response rate and duration of response. There is an ongoing study to confirm clinical benefit. a type of lung cancer called non-small cell lung cancer (NSCLC). TECENTRIQ may be used when your lung cancer*: has spread or grown, and you have tried chemotherapy that contains platinum, and it did not work or is no longer working ...
- Meta Keywords
- tecentriq, atezo, atezolizumab, genentech, biooncology, roche, urothelial bladder cancer treatment, urothelial bladder cancer therapy, pdl-1, pd-l1, pd-1, anti-pdl1, anti-pdl1 immunotherapy
- Technologies in use
- reCaptcha, jQuery, Font Awesome